当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 利润表

药明康德

(603259)

80.80

4.50  (5.90%)

今开:74.00最高:81.89成交:6.30万手 市盈:0.00 上证指数:2550.47   2.58%2018-10-19
昨收:76.30 最低:74.00 换手:0.00%振幅:0.00 深证指数:7387.74  2.79%15:30:59

集合

竞价

利润表

按照会计年度查询:
报告期2018-06-302018-03-312017-12-312017-09-30
一、营业总收入4,409,207,1792,141,764,392.117,765,259,856.285,677,878,889.76
营业收入4,409,207,1792,141,764,392.117,765,259,856.285,677,878,889.76
二、营业总成本3,470,226,774.081,794,223,129.776,428,779,845.564,503,977,124.97
营业成本2,642,683,523.021,304,294,322.674,516,794,368.383,250,216,204.65
营业税金及附加17,023,281.510,263,262.4525,722,702.216,452,490.76
销售费用152,679,970.5872,992,943.69291,509,533.65209,960,496.15
管理费用605,059,024.95269,043,886.61,269,334,048.92903,431,298.55
财务费用59,800,562.54138,328,963.76184,463,115.24116,364,346.34
资产减值损失-7,019,588.51-700,249.4140,956,077.177,552,288.52
三、其他经营收益-22,628,814.37--11,231,029.2822,895,094.22
允许价值变动净收益381,452,524.664,144,872.5677,565.75677,565.75
投资净收益59,609,150.73-1,267,961.2439,793,811.6339,659,177.63
联营、合营企业投资收益29,900,060.62-9,773,631.49----
汇兑净收益--------
四、营业利润1,415,358,866.37365,311,886.861,460,594,895.771,214,238,508.17
营业外收入13,125,820.593,512,380.66135,975,770.68177,428,241.96
营业外支出3,453,853.172,831,210.863,950,438.257,490,408.98
非流动资产处置净损失2,305,477.95----5,976,724.01
五、利润总额1,425,030,833.79365,993,056.661,592,620,228.21,384,176,341.15
所得税120,961,158.2961,775,065.28295,899,689.78269,276,962.99
未确认的投资损失--------
六、净利润(百万元)1,271.9290.661,227.091,063.04
少数股东损益32,172,478.6113,560,391.8469,627,059.1251,859,942.35
归属于母公司股东的净利润1,271,897,196.89290,657,599.541,227,093,479.31,063,039,435.81
七、每股收益1.310.311.311.13
基本每股收益1.31--1.311.13
稀释每股收益--------
TOP↑